| www.VBWG.org | US Chapter
Meeting
Chicago, Illinois March 29,
2008
Agenda
| Carl
J. Pepine, MD - National
Chairman |
| | 12:45 - 12:55
pm | Welcome and Opening Remarks | Chair: Carl J. Pepine, MD,
MACC University of Florida College of Medicine Gainesville, Florida Co-Chair: Peter Libby, MD,
FACC Harvard Medical School Boston,
Massachusetts |
| | Session I: Cardiovascular
Disease and a Look to the Future | | 12:55 - 1:15 pm | Keynote Address Bioartificial
Heart Generation: Using Natures Platform | Doris A. Taylor,
PhD University of Minnesota Minneapolis,
Minnesota
|
| | Session II: Advances in Vascular
Biology: Focus on Cell and Gene Therapies | | 1:15 - 1:25
pm | Allogenic Mesenchymal Stem Cells in Acute
MI | Timothy D. Henry, MD, FACC Minneapolis
Heart Institute Minneapolis, Minnesota
| | 1:25 - 1:35 pm | Effect of Progenitor Cell
Mobilization on Endothelial Function and Symptoms in Patients with PAD | Arshed A. Quyyumi, MD, FRCP, FACC Emory
University School of Medicine Atlanta, Georgia
| | 1:35 - 1:45 pm | Open Discussion | | | 1:45 - 1:55 pm | Role of Bone
Marrow in Cardiac Fibrosis | Douglas E. Vaughan, MD, FACC Vanderbilt University Medical Center Nashville,
Tennessee | | 1:55 - 2:05 pm | Imaging to Understand Stem Cell Biology | Joseph C. Wu, MD, PhD Stanford
University School of Medicine Palo Alto, California
| | 2:05 - 2:15 pm | Open Discussion | |
| | Session
III: Cardiac Imaging | | 2:15 2:25 pm | Nanoparticle Imaging of Macrophages
in Atherosclerotic Lesions | Peter Libby, MD,
FACC | | 2:25 2:35 pm | Myocardial Ischemic Memory Imaging
with Molecular Echocardiography | Jonathan R. Lindner, MD Oregon Health and Science University Portland, Oregon
| | 2:35 2:45 pm | Molecular Imaging of Apoptosis in
Atherosclerotic Lesions | Jagat Narula, MD, PhD, FACC,
FRCP University of California, Irvine Orange,
California | | 2:45 2:55 pm | Open Discussion | |
| | Session IV: Women at Risk
| | 2:55 3:05 pm | WISE Update: Women at High Risk
for Reduced CV Survival | Leslee J. Shaw, PhD, FASNC Emory University School of Medicine Atlanta, Georgia
| | 3:05 3:15 pm | Symptom Presentation of Women with
ACS: Myth vs Reality | Carl J. Pepine, MD, MACC | | 3:15 3:25
pm | Open Discussion | |
| | Session V: Interventions in ACS
and Other Settings | | 3:25 3:35 pm | Antiplatelet Therapy in PCI: New
Considerations | Stephen D. Wiviott, MD Harvard Medical
School Boston, Massachusetts
| | 3:35 3:45
pm | The
Evolving Landscape of Transcatheter Valve
Replacement/Repair | Peter C. Block, MD, FACC Emory
University School of Medicine Atlanta, Georgia
| | 3:45 3:55 pm | Open Discussion | |
| | Session VI: Cardiometabolic Risk and
Lifestyle | | 3:55 4:05 pm | CV Outcomes of Weight Loss: Trials
and Updates | W. Philip T. James, CBE, MD, DSc University of London School of Hygiene and Tropical
Medicine London, UK Chair, International Obesity
Task Force
| | 4:05 4:25 pm | Implications of the ENHANCE Trial for
Practicing Cardiologists | Robert M. Califf, MD, MACC Duke University Medical Center Duke Translational
Medicine Institute Durham, North Carolina
Steven E. Nissen, MD, MACC Heart and Vascular
Institute Cleveland Clinic Foundation Cleveland,
Ohio
| | 4:25 4:35 | Open Discussion | |
| | Session VII: Advances in Clinical Care
| | 4:35 4:45 pm | The STAT Registry: Addressing
Knowledge Gaps in Contemporary Acute Hypertension | Christopher B.
Granger, MD, FACC Duke University Medical Center Duke Clinical Research Institute Durham, North
Carolina
| | 4:45 4:55 pm | Anticoagulation for Stroke Prevention
in Patients with Atrial Fibrillation | Jeffrey L.
Anderson, MD, FACC, FAHA, MACP University of Utah
School of Medicine Salt Lake City, Utah | | 4:55 pm | Open
Discussion | | | | Adjourn | |
| | Top
^ | |